Home > Insider Trading > Filing (0001209191-21-027701)

Filing Details

Accession Number:: 0001209191-21-027701
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-20 21:30:12
Reporting Period:: 2021-04-16

Accepted Time:: 2021-04-20 21:30:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1601830	Recursion Pharmaceuticals Inc.	RXRX	Biological Products, (No Disgnostic Substances) (2836)	464099738

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1633331	Lux Ventures Iv, L.p.	920 Broadway, 11Th Floor New York NY 10010	No	No	Yes	No
1633332	Lux Venture Partners Iv, Llc	920 Broadway, 11Th Floor New York NY 10010	No	No	Yes	No
1722021	Lux Co-Invest Partners, Llc	920 Broadway, 11Th Floor New York NY 10010	No	No	Yes	No
1722022	Lux Co-Invest Opportunities, L.p.	920 Broadway, 11Th Floor New York NY 10010	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2021-04-16	100,000	$18.00	100,000	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2021-04-20	17,174,594	$0.00	17,187,095	No	4	C	Indirect	See footnote
Common Stock	Disposition	2021-04-20	17,187,095	$0.00	0	No	4	C	Indirect	See footnote
Class A Common Stock	Acquisiton	2021-04-20	17,187,095	$0.00	17,287,095	No	4	C	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2021-04-20	10,279,275	$0.00	10,279,275	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-04-20	3,578,653	$0.00	3,578,653	$0.00
Common Stock	Series C Preferred Stock	Disposition	2021-04-20	1,825,883	$0.00	1,825,883	$0.00
Common Stock	Series D Preferred Stock	Disposition	2021-04-20	1,490,783	$0.00	1,490,783	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

50,000 of these shares are held by Lux Co-Invest Opportunities, L.P. and 50,000 of these shares are held by Lux Ventures IV, L.P.
Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, LP and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P.
Each of Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, and the Individual Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein.
3,018,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,156,084 of these shares are held by Lux Ventures IV, L.P.
Each share of Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock automatically converted into Class A Common Stock on a 1:1 basis immediately prior to the completion of Recursion Pharmaceuticals, Inc.'s (the "Issuer") initial public offering of Class A Common Stock (the "IPO"). Each shares of Series C Preferred Stock automatically converted into Class A Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's IPO. The right to convert Common Stock, Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock into Class A Common Stock had no expiration date.
3,068,510 of these shares are held by Lux Co-Invest Opportunities, L.P. and 14,206,084 of these shares are held by Lux Ventures IV, L.P.
Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO.
Represents shares held of record by Lux Ventures IV, L.P.
Represents shares held of record by Lux Co-Invest Opportunities, L.P.
Represents 298,156 shares held of record by Lux Ventures IV, L.P. and 1,192,627 shares held of record by Lux Co-Invest Opportunities, L.P.